콘텐츠로 건너뛰기
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Menu
SOLUTIONS
Drug Discovery Sevices
Collaboration Partners
Platform
R&D
Platform Technology
Pipelines
Publications
Patent & Cert.
ABOUT US
Overview
History
Partnership
CI & BI
NEWS
Press Release
Seminars & Events
Notice
Responsibility
CAREER
Get In Touch
PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect.
News
04/07/2021
<View Original Article>
Post Views:
159
Prev
Previous
PharmCADD Raised $16M in Series B Funding.
Next
South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO.
Next